Source: Cairo – Reem El-Shishtawy
At a time when the whole world is working on research on the emerging corona virus, discovering new things every day around it and working on an effective vaccine for this virus that has infected millions around the world until now, and is still spreading, Egypt is proud of the participation of the Egyptian researcher in molecular virology and specialized in viruses Corona, Dr. Nisreen Mamdouh Oqba, who contributed to the discovery of an antibody coronavirus, through her work in the virology department at Erasmus University in Rotterdam, the Netherlands.
In an interview with Al-Arabiya.net, Dr. Nisreen Mamdouh Aqaba explained that she and her partners in research on this coronavirus were able to discover a monoclonal antibody, through which the behavior of Corona viruses could be modified, and thus stop the damage of this virus.
Dr. Nesreen confirmed that the research that corona viruses (Corona) have been working on for years depends heavily on the identification of antibodies that work to target weak sites on the surface proteins of these viruses, in order to detect treatment and develop vaccines against those coronavirus, where it can These antibodies alter the course of the infection of the infected person, thereby expelling the virus and protecting individuals from the risk of infection.
The virologist indicated that she has been working on corona virus research for more than 6 years, and the main goal of this research is to find methods for diagnosing, treating and producing vaccines for these viruses, and working to prepare for various scenarios if they spread.
Currently, the Erasmus University Research Center works with all research centers in Europe and the world, in coordination with the World Health Organization, to study the characteristics of the virus to find ways to limit its spread.
Dr. Nesreen pointed out that corona viruses are present in many animals of various types, and mutations of viruses are a natural thing that may lead to transmission to humans, so “we are working on how to prepare and face such scenarios when they occur.”
Dr. Nesreen also explained that the world faced the first climax of the emerging corona virus (SARS 2), and countries are working to avoid another climax of this virus, by maintaining preventive measures and reducing stress on health systems around the world.
Dr. Nisreen continued that although countries are accelerating in reaching an effective vaccine for Corona and reaching treatments for this disease, the stages of vaccine trials must be completed properly, in normal times this may take a few years, but in the current situation these measures are accelerated to months, as The rates of experiments currently being performed are very good.
It is worth noting that Dr. Nisreen Okba, who graduated from the Faculty of Pharmacy at the University of Tanta in 2005, obtained a master’s degree in microbiology from the University of Tanta, and worked as a researcher in the Department of Virology at Erasmus University in Rotterdam, the Netherlands since 2014, as well as during The coming days you will discuss his PhD in virology and specialist in corona viruses.